chevron_leftBack
O
As of 24 April 2025, Oaktree Acquisition Corp. III Life Sciences has a market cap of $248.29M USD, ranking #16012 globally and #2758 in the United States. It ranks #1645 in the Financial Services sector, and #46 in the Shell Companies industry.
Key Stats
Market Cap
$248.29MUSD
Enterprise Value
$246.94MUSD
Net Income (TTM)
$2.66MUSD
PE Ratio
93.2
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Shell Companies
CEO
Zaid Pardesi
open_in_new
Founded
2024
IPO
24 Oct 2024
Website
oaktreeacquisitioncorp.com/oac-iii
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.3% | -0.1% | -0.4% | 1.1% | 1% | 1% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
OACC
Oaktree Acquisition Corp III Life Sciences Class A Ordinary shares
ISIN: KYG6717R1048
Shares Out.:
Shares Outstanding:
19.783M1
Shares Float:
19.783M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
10.10 USD | |
|
NASDAQ
MIC: XNAS
|
OACCU
Oaktree Acquisition Corp III Life Sciences Units (1 Shs Cls A & 1/5 Warr)
ISIN: KYG6717R1204
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
10.31 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
